Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Monoclonal antibodies targeted against COVID-19 have high potential, but their efficacy against emerging variants remains muddled, says GlobalData

The emergence of new SARS-CoV-2 variants have been detected in over 40 countries and are disrupting drug development worldwide. The prevalence of these more transmissible strains is growing fast and may require adjustments to current therapies to ensure they retain clinical efficacy, says GlobalData, a leading data and analytics company. Nancy Jaser, PharmD/MBA, Pharma Analyst […]
Read more

SalioGen therapeutics’ non-viral gene therapy platform may potentially expand access to novel rare disease therapeutics, says GlobalData

In March 2021, SalioGen therapeutics raised $20m to support the preclinical validation of its non-viral gene therapy platform, exact DNA integration technology. The development of non-viral gene therapy manufacturing platforms will likely increase patient access to gene therapy and improve the cost-to-benefit ratio, says GlobalData, a leading data and analytics company. SalioGen has engineered a […]
Read more

Blockchain technology provides a potential game changer for clothing supply chain transparency and sustainability, says GlobalData

As governments around the world crack down on companies whose supply chains are linked to forced labour and other unethical and unsustainable practices, clothing retailers that have not considered introducing blockchain technologies to help provide them with supply chain transparency stand to lose out, says GlobalData, a leading data and analytics company. Blockchain technologies enables […]
Read more

Russian construction industry set to grow by 2.6% in 2021 due to infrastructure investments, says GlobalData

The Russian construction industry contracted marginally in 2020, with output declining by 0.7% in real terms. The lockdown measures and subsequent economic slowdown, as well as the severe dip in oil and gas prices weakened the construction industry. However, supported by investment in major infrastructure projects, rising oil prices and global economic recovery, the industry […]
Read more

University Technology Licensing Program will boost novel drug development, says GlobalData

The University Technology Licensing Program (UTLP) was created to improve innovation in multiple sectors and facilitate more efficient licensing between commercial companies and the 15 universities in the program. The UTLP participating universities have a sizeable pipeline of over 240 early-stage drugs that could be out-licensed, say GlobalData, a leading data and analytics company. The […]
Read more

Petrobras must play its part to invest in other less capital-intensive sustainability efforts to reduce emission, says GlobalData

Despite a global effort in energy transition, Petrobras has expressed no interest to pivot into renewable energy due to lack of expertise. As a leader in Brazil, it must play its part to invest in other less capital-intensive sustainability efforts to reduce emission, says GlobalData, a leading data and analytics company. The company laid out […]
Read more

Anticipated boom in summer holiday bookings dampened by uncertainty over travel restrictions, says GlobalData

European operators were banking on summer 2021 providing an opportunity to start generating some much-needed income. However, many travelers have remained hesitant and the anticipated boom in travel may not occur to the desired extent. With uncertainty over what travel restrictions will be in place, many travelers remain reluctant to book, says GlobalData, a leading […]
Read more

AstraZeneca needs to regain public trust by showing benefits of COVID-19 vaccine far outweigh risks, says GlobalData

Following the news that the European Medicines Agency (EMA) has confirmed a possible link between very rare cases of unusual blood clots after vaccination with AstraZeneca’s COVID-19 vaccine Vaxzevria; Philipp Rosenbaum, PhD, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “AstraZeneca has had its fair share of bad luck […]
Read more
1 … 58 59 60